Loading...

Euroapi S.A.

EAPI.PAEURONEXT
Healthcare
Medical - Devices
2.70
-0.01(-0.30%)

Euroapi S.A. (EAPI.PA) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Euroapi S.A. (EAPI.PA), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
-9.79%
9.79%
Operating Income Growth
48.61%
48.61%
Net Income Growth
31.15%
31.15%
Operating Cash Flow Growth
2309.80%
2309.80%
Operating Margin
-6.83%
6.83%
Gross Margin
15.04%
15.04%
Net Profit Margin
-14.29%
14.29%
ROE
-13.95%
13.95%
ROIC
-5.37%
5.37%

Euroapi S.A. (EAPI.PA) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Euroapi S.A. EAPI.PA financial performance.

MetricQ4 2024Q2 2024Q4 2023Q3 2023
Revenue$463.20M$450.90M$516.60M$260.20M
Cost of Revenue$423.70M$352.90M$452.10M$226.45M
Gross Profit$39.50M$98.00M$64.50M$33.75M
Gross Profit Ratio$0.09$0.22$0.12$0.13
R&D Expenses$11.90M$13.90M$16.30M$8.15M
SG&A Expenses$61.70M$66.60M$66.80M$34.10M
Operating Expenses$68.50M$131.40M$79.30M$159.20M
Total Costs & Expenses-$492.20M$484.30M$531.40M$385.65M
Interest Income$3.00M$6.20M$2.20M$2.25M
Interest Expense$13.50M$22.40M$7.90M$0.00
Depreciation & Amortization$30.90M$27.50M$41.70M$129.55M
EBITDA-$53.60M-$4.90M-$208.60M$121.25M
EBITDA Ratio-$0.12-$0.01$0.05$0.47
Operating Income-$29.00M-$33.40M-$14.80M-$8.30M
Operating Income Ratio-$0.06-$0.07-$0.03-$0.03
Other Income/Expenses (Net)-$69.10M-$8.10M-$130.35M-$2.55M
Income Before Tax-$98.10M-$41.50M-$255.50M-$127.70M
Income Before Tax Ratio-$0.21-$0.09-$0.49-$0.49
Income Tax Expense-$2.30M-$6.70M-$3.00M$1.45M
Net Income-$95.80M-$34.80M-$252.50M-$126.25M
Net Income Ratio-$0.21-$0.08-$0.49-$0.49
EPS-$1.01-$0.37-$2.66-$1.34
Diluted EPS-$1.01-$0.36-$2.66-$1.34
Weighted Avg Shares Outstanding$95.23M$94.05M$94.84M$94.20M
Weighted Avg Shares Outstanding (Diluted)$95.23M$95.90M$94.84M$94.50M

Over the last four quarters, Euroapi S.A.'s revenue moved from $260.20M in Q3 2023 to $463.20M in Q4 2024. Operating income in Q4 2024 was -$29.00M, with a strong operating margin of -6%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Euroapi S.A. remained robust at -$53.60M, reflecting operational efficiency. Net income dropped to -$95.80M, with an EPS of -$1.01. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;